Switch to
More onapp

Tyche Industries Ltd

TYCHE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹129 cr, stock is ranked 2,050
Moderate RiskStock is 2.71x as volatile as Nifty
126.000.10 (+0.08%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹129 cr, stock is ranked 2,050
Moderate RiskStock is 2.71x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
13.83
PB RatioPB Ratio
1.24
Dividend YieldDiv. Yield
1.19%
Sector PESector PE
35.84
Sector PBSector PB
4.35
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Tyche Industries Limited is an India-based company that is engaged in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates and nutraceuticals. The Company primarily manufactures bulk drug intermediates. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal. Its intermediaries include 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, 3-Fluoro-4-methoxy acetophenone, 3-Hydroxymethyl quinuclidine HCl, (RS)-3-Quinuclidinol, 3-Quinuclidinone Hydrochloride and 1-Benzylpiperidine-4-Carboxaldehyde (BPCA). Its nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

Financial TrendFinancial statements 

201920202021202256.4777.3882.9867.387.1617.5619.989.33
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Result 
Announced OnNov 10, 2022

TYCHE INDUSTRIES LTD. - 532384 - Financial Results For The Quarter And Half Year Ended 30Th September 2022 | Download

TYCHE INDUSTRIES LTD. - 532384 - Financial Results For The Quarter And Half Year Ended 30Th September 2022 | Download

Board Meeting 
Announced OnNov 10, 2022

TYCHE INDUSTRIES LTD. - 532384 - Board Meeting Outcome for Outcome Of Board Meeting | Download

TYCHE INDUSTRIES LTD. - 532384 - Board Meeting Outcome for Outcome Of Board Meeting | Download

Cash Dividend 
Ex. DateSep 22, 2022

Final • Div/Share: ₹ 1.5

See all events